Biology of Blood and Marrow Transplantation
Volume 18, Issue 2 , Pages 190-199, February 2012

The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications

  • Håkon Reikvam

      Affiliations

    • Division for Hematology, Institute of Medicine, University of Bergen, Norway
    • Department of Medicine, Haukeland University Hospital, Haukeland, Norway
  • ,
  • Knut Anders Mosevoll

      Affiliations

    • Department of Medicine, Haukeland University Hospital, Haukeland, Norway
  • ,
  • Guro Kristin Melve

      Affiliations

    • Departemnt of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway
  • ,
  • Clara-Cecilie Günther

      Affiliations

    • Norwegian Computing Center, Oslo, Norway
  • ,
  • Malvin Sjo

      Affiliations

    • Department of Medicine, Haukeland University Hospital, Haukeland, Norway
  • ,
  • Pål-Tore Bentsen

      Affiliations

    • Department of Medicine, Haukeland University Hospital, Haukeland, Norway
  • ,
  • Øystein Bruserud

      Affiliations

    • Division for Hematology, Institute of Medicine, University of Bergen, Norway
    • Department of Medicine, Haukeland University Hospital, Haukeland, Norway
    • Corresponding Author InformationCorrespondence and reprint requests: Professor Øystein Bruserud, Medical Department, Haukeland University Hospital, N-5021 Bergen, Norway.

Received 6 June 2011; accepted 7 October 2011. published online 21 October 2011.

Cytokines play a key role in regulation of normal and malignant hematopoiesis, angiogenesis, and inflammation. Serum levels of several cytokines are altered in patients with hematologic malignancies, and pretransplant cytokine levels seem to have a prognostic impact in patients treated with allogeneic stem cell transplantation. However, the cytokine system constitutes an interacting functional network, and it may therefore be more relevant to look at serum cytokine profiles rather than the serum levels of single cytokines in allotransplanted patients. We therefore investigated the pretransplantation serum levels of 35 cytokines in a group of 44 consecutive allogeneic stem cell transplantation patients, mainly with a primary diagnosis of acute leukemia. Serum samples were collected before the start of myeloablative conditioning therapy when all patients were in complete hematologic remission. Unsupervised hierarchical clustering analysis identified three major patient groups/subsets. These groups differed especially in the levels of hepatocyte growth factor and granulocyte-colony stimulating factor, and one of the groups was characterized by low early treatment-related morbidity and high levels of hepatocyte growth factor and granulocyte-colony stimulating factor. The degree of weight gain/fluid retention after conditioning therapy did not differ between the patient subsets, but fluid retention showed a significant correlation with pretransplantation serum levels of basic fibroblast growth factor. We conclude that the pretransplantation serum cytokine profile shows a considerable variation even between patients in complete hematologic remission and is associated with clinicopathologic features.

Key Words: Cytokines, Allogeneic stem cell transplantation, Acute leukemia, Angiogenesis, Graft-versus-host disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial disclosure: See Acknowledgments on page 199.

PII: S1083-8791(11)00410-1

doi:10.1016/j.bbmt.2011.10.007

Biology of Blood and Marrow Transplantation
Volume 18, Issue 2 , Pages 190-199, February 2012